Buy or sell Boston Scientific stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Boston Scientific Stock

Innovator of medical solutions that improve the health

About Boston Scientific Stock

Boston Scientific is a leading innovator of medical solutions that improve the health of patients around the world. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health and chronic pain conditions. Boston Scientific's journey of innovation began in 1979, when their revolutionary steerable catheters were first used in less-invasive procedures. Today, Boston Scientific continues their legacy of delivering meaningful innovation to meet patient needs around the world and deliver economic value to their customers. Boston Scientific has advanced the practice of less-invasive medicine by providing a broad and deep portfolio of innovative products, technologies and services across a wide range of medical specialties. These less-invasive medical technologies provide alternatives to major surgery and other medical procedures that are typically traumatic to the body. In less-invasive procedures, devices are usually inserted into the body through natural openings or small incisions and can be guided to most areas of the anatomy to diagnose and treat a wide range of medical problems. Boston Scientific continues to innovate in these areas and are extending their innovations into new geographies and high-growth adjacency markets. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Boston Scientific acts with integrity and compassion to support patients, customers, our communities and each other. Boston Scientific fosters an environment of creativity to transform new ideas into breakthrough services and solutions that create value for patients, customers and employees. Boston Scientific strives for high performance to benefit their patients, clinicians and shareholders and they work collaboratively to pursue global opportunities that extend the reach of their medical solutions.

Funding History

February 2018$1.0B

Management

President & CEO

Michael Mahoney

Press

FDA Panel Assesses Risks of Women’s Surgical Mesh

Wall Streets Journal - Feb, 12 2019

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Boston Scientific or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 100K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo